Physician profile
Taylor Dandrea
NPI 1902306608
$2,031.52
in general payments reported to CMS, 2019-2025
10 companies · $303 in 2025
The $303 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $30.08 · 2022: $12.99 · 2024: $1,685 · 2025: $303.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,198 · Food and Beverage: $776 · Entertainment: $14.07.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,198.23 |
| Food and Beverage | $776.15 |
| Entertainment | $14.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $1,649.38 | 2024-2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Medtronic, INC. | $114.50 | 2025 | Freestyle |
| Abiomed | $86.45 | 2024-2025 | Impella |
| Stryker Corporation | $50.91 | 2025 | Spy-Phi System |
| Edwards Lifesciences Corporation | $43.42 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $28.57 | 2021-2025 | Lifevest |
| Pfizer INC. | $15.94 | 2021 | |
| Haemonetics Corporation | $15.29 | 2025 | Teg6s Hemostasis System |
| Argentum Medical | $14.07 | 2025 | |
| Kci USA, INC. | $12.99 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taylor Dandrea listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.